πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8252538

MicroRNA expression signature for predicting survival and metastases in hepatocellular car

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247228

Method of inducing memory B cell development and terminal differentiation

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247225

DNA promoters and anthrax vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8247183

Compositions and methods for diagnosis and treatment of tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8246931

Development of a quail embryo model for the detection of botulinum toxin

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8242160

Inhibitors of ubiquitin E1

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8236313

Prevention of tissue ischemia, related methods and compositions

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8232379

Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8232259

Multiple CpG oligodeoxynucleotide and their use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8227421

Fluorinated GHRH antagonists

The United States of America represented by the Department of Veteran Affairs Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8227417

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8227438

Suppressors of CpG oligonucleotides and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8227443

Silencing of CSN5 gene expression using interfering RNA

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8227446

Oligodeoxynucleotide and its use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8221768

Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8222225

Method of treating pneumoconiosis with oligodeoxynucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8217158

Immunotoxin fusion proteins and means for expression thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8216565

GP100-specific T cell receptors and related materials and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8211445

PSM peptides as vaccine targets against methicillin-resistant Staphylococcus

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8211447

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8211422

Chimeric receptor genes and cells transformed therewith

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8207142

Inhibitor of DNA methylation

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8206933

Boris isoforms and methods of detecting and treating disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8202551

Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical appl

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted